LALPATHLAB Relative Valuation - Dr. Lal PathLabs Ltd

Watchlist Manager

Watchlist

Price: 1 332.2 INR -0.58% Market Closed

Market Cap: ₹222.4B

Relative Value

The Relative Value of one LALPATHLAB stock under the Base Case scenario is hidden INR. Compared to the current market price of 1 332.2 INR, Dr. Lal PathLabs Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

LALPATHLAB Relative Value

Show

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
IN		Dr. Lal PathLabs Ltd NSE:LALPATHLAB	222.2B INR	8.4	42.1	28.1	34.8
US		CVS Health Corp NYSE:CVS	96.9B USD	0.2	54	13.9	13.9
US	C	Cigna Group XMUN:CGN	68.1B EUR	0.3	13.3	7.8	9.9
US		Cigna Corp NYSE:CI	71.1B USD	0.3	11.7	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	26.3B EUR	1.1	20.6	9.7	14.4
DE		Fresenius Medical Care AG XMUN:FME	23.4B EUR	1.2	23.9	9.2	17
US		Laboratory Corporation of America Holdings NYSE:LH	21.9B USD	1.6	25.4	12.2	17.6
US		Quest Diagnostics Inc NYSE:DGX	21.9B USD	2	22.2	12.2	16.5
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.2B EUR	0.6	11.5	5.5	10.1
US		Guardant Health Inc NASDAQ:GH	11.6B USD	11.7	-27.6	-30.1	-27.4
US		DaVita Inc NYSE:DVA	10.3B USD	0.8	13.9	7.2	9.7

				Revenue Growth	P/S to Growth
IN		Dr. Lal PathLabs Ltd NSE:LALPATHLAB	Average P/S: 2.6 8.4	12%	0.7
US		CVS Health Corp NYSE:CVS	0.2	4%	0.1
US	C	Cigna Group XMUN:CGN	0.3	6%	0
US		Cigna Corp NYSE:CI	0.3	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.1	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.2	3%	0.4
US		Laboratory Corporation of America Holdings NYSE:LH	1.6	6%	0.3
US		Quest Diagnostics Inc NYSE:DGX	2	5%	0.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.6	3%	0.2
US		Guardant Health Inc NASDAQ:GH	11.7	30%	0.4
US		DaVita Inc NYSE:DVA	0.8	4%	0.2

				Earnings Growth	PEG
IN		Dr. Lal PathLabs Ltd NSE:LALPATHLAB	Average P/E: 23.9 42.1	13%	3.2
US		CVS Health Corp NYSE:CVS	54	90%	0.6
US	C	Cigna Group XMUN:CGN	13.3	19%	0.7
US		Cigna Corp NYSE:CI	11.7	19%	0.6
DE		Fresenius SE & Co KGaA XETRA:FRE	20.6	26%	0.8
DE		Fresenius Medical Care AG XMUN:FME	23.9	16%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	25.4	27%	0.9
US		Quest Diagnostics Inc NYSE:DGX	22.2	12%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.5	16%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -27.6	N/A	N/A
US		DaVita Inc NYSE:DVA	13.9	21%	0.7

				EBITDA Growth	EV/EBITDA to Growth
IN		Dr. Lal PathLabs Ltd NSE:LALPATHLAB	Average EV/EBITDA: 11.7 28.1	13%	2.2
US		CVS Health Corp NYSE:CVS	13.9	28%	0.5
US	C	Cigna Group XMUN:CGN	7.8	4%	1.9
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	9.7	10%	1
DE		Fresenius Medical Care AG XMUN:FME	9.2	7%	1.3
US		Laboratory Corporation of America Holdings NYSE:LH	12.2	10%	1.2
US		Quest Diagnostics Inc NYSE:DGX	12.2	7%	1.7
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	5.5	7%	0.8
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -30.1	N/A	N/A
US		DaVita Inc NYSE:DVA	7.2	4%	1.8

				EBIT Growth	EV/EBIT to Growth
IN		Dr. Lal PathLabs Ltd NSE:LALPATHLAB	Average EV/EBIT: 16 34.8	14%	2.5
US		CVS Health Corp NYSE:CVS	13.9	22%	0.6
US	C	Cigna Group XMUN:CGN	9.9	6%	1.6
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	14.4	13%	1.1
DE		Fresenius Medical Care AG XMUN:FME	17	17%	1
US		Laboratory Corporation of America Holdings NYSE:LH	17.6	18%	1
US		Quest Diagnostics Inc NYSE:DGX	16.5	10%	1.6
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.1	17%	0.6
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -27.4	N/A	N/A
US		DaVita Inc NYSE:DVA	9.7	5%	1.9

Dr. Lal PathLabs Ltd
NSE:LALPATHLAB

Relative Value

Valuation Multiples

Multiples Across Competitors

LALPATHLAB Competitors Multiples
Dr. Lal PathLabs Ltd Competitors

See Also

Company

Help

Tools

Stocks

Dr. Lal PathLabs Ltd NSE:LALPATHLAB

Relative Value

Valuation Multiples

Multiples Across Competitors

LALPATHLAB Competitors Multiples Dr. Lal PathLabs Ltd Competitors

See Also

Company

Help

Tools

Stocks

Dr. Lal PathLabs Ltd
NSE:LALPATHLAB

LALPATHLAB Competitors Multiples
Dr. Lal PathLabs Ltd Competitors